首页> 外文期刊>Bulletin of the Korean Chemical Society >Novel DPP-IV-resistant Analogs of GLP-1: The N-terminal Extension of GLP-1 by a Single Amino Acid
【24h】

Novel DPP-IV-resistant Analogs of GLP-1: The N-terminal Extension of GLP-1 by a Single Amino Acid

机译:新型抗DPP-IV的GLP-1类似物:单个氨基酸对GLP-1的N端延伸

获取原文
获取原文并翻译 | 示例
           

摘要

Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced from intestinal L cells of the gut and plays an important role in glucose-dependent insulin secretion, suppression of glucagon secretion, proliferation of pancreatic β-cells, and inhibition of food intake. The short half-life of GLP-1 (t_(1/2) < 2 minutes) resulted from degradation by dipeptidyl peptidase IV (DPP-IV), however, has stymied the application of GLP-1 for the treatment of insulin-resistant type 2 diabetes. Exendin-4, which is derived from saliva of a lizard Gila monster with ~53% sequence homology with GLP-1, has Gly in position 2 rather than Ala, as is the case in GLP-1. Thus, exendin-4 is resistant to the cleavage by DPP-IV and has a half-life of approximately 30 minutes after intravenous administration and 2-3 hours after subcutaneous administration in humans.'
机译:胰高血糖素样肽1(GLP-1)是从肠道小肠L细胞产生的肠降血糖素激素,在葡萄糖依赖性胰岛素分泌,胰高血糖素分泌抑制,胰岛β细胞增殖和抑制胰岛素中起重要作用。食物的摄入量。 GLP-1的半衰期短(t_(1/2)<2分钟)是由于二肽基肽酶IV(DPP-IV)降解而引起的,然而,这阻碍了GLP-1在胰岛素抵抗治疗中的应用2型糖尿病。 Exendin-4(它来自蜥蜴吉拉怪物的唾液,与GLP-1的序列同源性约为53%)与GLP-1一样,其Gly在位置2而不是Ala。因此,exendin-4对DPP-IV的切割具有抗性,在人中静脉内给药后的半衰期约为30分钟,皮下给药后的半衰期为2-3小时。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号